Peptides, Skin & Tattoos

A Telegraph investigation published in April did what most mainstream outlets won't — it went inside the peptide grey market and followed the people injecting compounds with names like "Barbie drug", "Smurf Juice" and "Triple G". The piece is worth reading in full. But as someone who spends most of their working life very close to people's skin, I want to add a layer the article didn't cover.

Peptides aren't just a fitness story. They're a skin story. And skin is my medium.

What's actually happening out there

In case you haven't seen the coverage: a growing grey market sells lab-synthesised peptide compounds online, typically labelled "for research purposes only" to sidestep regulation. Influencers — some with tens of thousands of followers — document their self-injection protocols on TikTok and Instagram, covering compounds like Melanotan II, BPC-157, GHK-Cu and retatrutide. None of these are approved for general use in the UK. Most have limited or zero human safety data. Many are sourced from overseas labs with no sterility guarantees.

The Medicines and Healthcare products Regulatory Agency (MHRA) has made its position clear: where these products are promoted or used as medicines, existing law applies. That hasn't slowed the market down noticeably.

In the fitness and bodybuilding world — which overlaps heavily with tattoo culture — peptides are being discussed in the same breath as protein shakes and sleep tracking. They've been normalised fast. And several of them directly affect the skin you're eventually going to ask me to tattoo.

Melanotan II and what it does to your canvas

Melanotan II, or MT II, is the one that concerns me most from a tattooing perspective. It works by stimulating melanin production — artificially deepening skin tone with less sun exposure. For people who tan poorly or suffer from certain skin conditions, the appeal is obvious. The Telegraph article follows a Sheffield-based influencer who credits it with improving his eczema.

But here's what that means practically. Melanin is the pigment we're working around — and sometimes working with — every time we tattoo. A significant shift in your baseline melanin level changes the canvas. It can affect how colours read, how contrast sits, how blacks age. If you started using MT II six months ago and your skin tone has shifted meaningfully, the design we drew up for your original skin may not behave the same way once it heals.

There are harder concerns too. MT II is known to increase the number and darkness of moles and freckles. Existing moles can enlarge. Cancer Research UK is explicit that it does not protect against skin damage and that users have an elevated skin cancer risk. From a tattooing standpoint, a new or changing mole in a tattooed area is a problem — both aesthetically and clinically. We don't tattoo over suspicious lesions. If your mole map is actively changing, we need to know that before you book.

The healing peptides — BPC-157 and the "Wolverine stack"

BPC-157 and TB-500 are marketed together as the "Wolverine stack", the idea being near-superhuman recovery — train harder, heal faster, push past natural limits. The science behind BPC-157 is more interesting than most grey-market compounds: there's a body of animal research, some promising early human studies, and a Croatian professor who has spent decades isolating and studying it.

For tattoo healing, the logic of "heal faster" sounds appealing. People ask me sometimes whether something like BPC-157 would speed up their tattoo recovery. My honest answer is: I don't know, and that's exactly the problem.

Tattoo healing is an inflammatory process. The skin needs to go through a controlled sequence — wound response, immune activity, cell turnover — to lock the pigment correctly. Anything that significantly alters that sequence is a variable I can't account for. We don't have data on how compounds that modulate blood vessel formation and tissue repair interact with tattoo ink deposition and retention. That's not a theoretical concern. That's a real gap in the science.

The Telegraph quotes Dr Rachael Dickman of UCL, who notes that many grey-market products "aren't clean" — the manufacturing process for injectable-grade compounds is categorically different from lab-grade research use. Contaminated injectables don't just fail to work. They can cause infection and immune responses. A compromised immune response during tattoo healing is the last thing either of us wants.

GHK-Cu and the anti-ageing angle

GHK-Cu, or "Smurf Juice" — so named for the blue-green colour it can turn in solution — is marketed for skin rejuvenation, hair growth and anti-ageing. The compound exists naturally in human plasma and genuinely does appear to have some role in tissue remodelling and collagen stimulation, though the evidence base for injectable supplementation in healthy adults is thin.

The reason it's relevant here: tattooed skin ages differently from untattooed skin. Collagen and elastin structure affects how lines hold and how colour stays vibrant. Compounds marketed to aggressively remodel skin tissue at the cellular level are, at minimum, an unknown variable for tattoo longevity. I'm not saying they'll ruin your ink. I'm saying nobody knows, because nobody has studied it.

The grey market parallel

There's something that resonates personally about the broader peptide story. The tattoo industry spent decades operating in a regulatory grey zone — unregulated inks, no standardised sterilisation requirements, a culture of self-policing and word-of-mouth quality signals. It caused real harm. Ink contamination, infections, allergic reactions, hepatitis transmission. The professionalisation of the industry — licensing, blood-borne pathogens training, EU pigment regulations — happened because of those failures, not in spite of some idealised freedom.

The people injecting grey-market peptides in their kitchens aren't stupid. Many of them are highly informed, running their own blood panels, sourcing from labs they've researched, treating themselves as experiments in a rigorous way. Kim Constable, profiled in the Telegraph piece, has six-monthly private blood tests and has compounds tested for purity before using them. That's more diligence than most people apply to their supplements.

But diligence doesn't replace clinical trials. And the counterfeit layer of this market — the cheap vials from unverified sources, the underground labs uncovered by Europol and the MHRA — sits right alongside the careful biohackers. The same distribution channels, the same social media corridors. The risk isn't evenly distributed, and the people most likely to take shortcuts are not the ones documenting their blood panels on Telegram.

What I'm actually watching for

Practically speaking, here's what I pay attention to in consultations now: active skin changes — new moles, shifting pigmentation, unusual healing from minor cuts. Changes in skin texture that the client can't explain. Clients who mention fitness supplementation and aren't sure what's in their stack.

I'm not trying to police what people put in their bodies. That's not my job and not something I'd want to do. But your skin is my medium, and I have a professional interest in understanding it as it actually is — not as it was six months ago before you started a protocol.

The peptide wave isn't going to recede. Robert F Kennedy Jr has already signalled moves to relax US restrictions on compounds like BPC-157 and GHK-Cu. Demand is running well ahead of regulation and the influencer infrastructure feeding that demand is enormous. More clients will be using these compounds. More of them will be sitting in my chair.

So tell me what you're using. That's all. We'll go from there.